Time course dissection of the Immune Component of Breast Cancer during treatment with targeted- and chemotherapy
- Prosjektnummer
- 2015057
- Ansvarlig person
- Vessela N. Kristensen
- Institusjon
- Akershus universitetssykehus HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 6. Treatment Evaluation
nei
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Nat Commun 2019 Dec 03;10(1):5499. Epub 2019 des 3
PMID: 31796750
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab.
Oncoimmunology 2018;7(11):e1457598. Epub 2018 aug 6
PMID: 30377556 - Inngår i doktorgradsavhandlingen
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Genome Med 2018 11 29;10(1):92. Epub 2018 nov 29
PMID: 30497530
Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.
Mol Oncol 2018 Sep;12(9):1540-1558. Epub 2018 aug 9
PMID: 29741811
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.
Oncotarget 2017 Aug 22;8(34):57121-57133. Epub 2017 jul 7
PMID: 28915659 - Inngår i doktorgradsavhandlingen
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
Oncoimmunology 2016;5(12):e1248015. Epub 2016 okt 24
PMID: 28123884
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Genome Biol 2016 Dec 09;17(1):250. Epub 2016 des 9
PMID: 27931250
A systematic comparison of copy number alterations in four types of female cancer.
BMC Cancer 2016 Nov 22;16(1):913. Epub 2016 nov 22
PMID: 27876019
Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
Thromb Res 2016 Sep;145():78-83. Epub 2016 aug 3
PMID: 27505249
Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients.
Cancer Res 2016 Sep 15;76(18):5326-36. Epub 2016 jul 12
PMID: 27406829
Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells.
Mol Oncol 2015 Dec;9(10):2054-62. Epub 2015 okt 23
PMID: 26607741
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.
Mol Cancer Res 2015 Mar;13(3):493-501. Epub 2014 okt 28
PMID: 25351767
- Olav Engebråten Medveileder
- Xavier Tekpli Medveileder
- Vessela N. Kristensen Hovedveileder
- Marianne Eikhom Nome Doktorgradsstipendiat (finansiert av denne bevilgning)
- Jürgen Geisler Prosjektdeltaker
- Shakila Jabeen Prosjektdeltaker
- Torben Luders Prosjektdeltaker
- Andliena Tahiri Prosjektdeltaker
- Bjørn Naume Forskningsgruppeleder
- Sunniva Maria Stordal Bjørklund Postdoktorstipendiat
- Surendra Kumar Postdoktorstipendiat
- Ida Rashida Khan Bukholm Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport